Sun Pharma spurts on buyback plan

Sun Pharmaceutical Industries rallied 6.50% to Rs 377.90 after the company said its board will consider share buyback on Tuesday, 17 March 2020.

The announcement was made after market hours yesterday, 12 March 2020. The stock hit a 52-week low at Rs 336.55 in early trade today.

Shares of Sun Pharmaceutical Industries dropped 12.53% in the past five trading sessions to settle at Rs 354.85 yesterday, 12 March 2020 from its close of Rs 405.70 on 4 March 2020.

Sun Pharmaceutical Industries' consolidated net profit tanked 26.4% to Rs 913.52 crore on a 5% increase in net sales to Rs 8,038.65 crore in Q3 December 2019 over Q3 December 2018.

Sun Pharmaceutical Industries' business segments include US Business, Indian branded generics business, Emerging markets, Global consumer healthcare business and Active Pharmaceutical Ingredients (API).

Powered by Capital Market - Live News